Syros Pharmaceuticals, Inc. Quarterly Current Ratio in % from Q1 2017 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Syros Pharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q1 2017 to Q3 2024.
  • Syros Pharmaceuticals, Inc. Current Ratio for the quarter ending September 30, 2024 was 320 %, a 46.2% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 320 -274 -46.2% Sep 30, 2024
Q2 2024 366 -286 -43.9% Jun 30, 2024
Q1 2024 407 -147 -26.5% Mar 31, 2024
Q4 2023 507 +12.3 +2.48% Dec 31, 2023
Q3 2023 594 +156 +35.7% Sep 30, 2023
Q2 2023 652 +263 +67.4% Jun 30, 2023
Q1 2023 554 +45.7 +8.99% Mar 31, 2023
Q4 2022 495 -109 -18% Dec 31, 2022
Q3 2022 438 -218 -33.3% Sep 30, 2022
Q2 2022 390 -228 -36.9% Jun 30, 2022
Q1 2022 508 -66.4 -11.6% Mar 31, 2022
Q4 2021 604 +87 +16.8% Dec 31, 2021
Q3 2021 656 +179 +37.5% Sep 30, 2021
Q2 2021 618 +97.4 +18.7% Jun 30, 2021
Q1 2021 575 -11 -1.87% Mar 31, 2021
Q4 2020 517 -43 -7.67% Dec 31, 2020
Q3 2020 477 -95.9 -16.7% Sep 30, 2020
Q2 2020 520 -69.1 -11.7% Jun 30, 2020
Q1 2020 586 +11.3 +1.96% Mar 31, 2020
Q4 2019 560 -25.9 -4.42% Dec 31, 2019
Q3 2019 573 -30.7 -5.09% Sep 30, 2019
Q2 2019 590 -80.7 -12% Jun 30, 2019
Q1 2019 574 -171 -23% Mar 31, 2019
Q4 2018 586 -321 -35.4% Dec 31, 2018
Q3 2018 604 -419 -41% Sep 30, 2018
Q2 2018 670 -418 -38.4% Jun 30, 2018
Q1 2018 746 -241 -24.4% Mar 31, 2018
Q4 2017 906 Dec 31, 2017
Q3 2017 1.02K Sep 30, 2017
Q2 2017 1.09K Jun 30, 2017
Q1 2017 986 Mar 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.